The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $948,703 in first-year total cost, median $238,950.
Most frequent study sections
- Clinical Research and Field Studies of Infectious Diseases Study Section[CRFS]2
- Pregnancy and Neonatology Study Section[PN]1
- Vaccines Against Microbial Diseases Study Section[VMD]1
Most frequent institutions
- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER1
- MAGEE-WOMEN'S RES INST AND FOUNDATION1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | A Phase 1 PK and Safety Study of Velpatasvir/Sofosbuvir for Chronic Hepatitis C Infection in Pregnant Women1R21HD101996-01 | CHAPPELL, CATHERINE | MAGEE-WOMEN'S RES INST AND FOUNDATION, PA | $267,981 | CRFS |
| 2020 | The diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences1R21HD100821-01 | KLAUSNER, JEFFREY DAVIDMORRONI, CHELSEA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $202,822 | CRFS |
| 2019 | Development of Immunotherapeutic Strategies to Overcome Neonatal Candidiasis1R21HD097480-01 | UPPULURI, PRIYA | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, CA | $243,150 | VMD |
| 2018 | The role of placental secreted factors in teratogenic virus infections1R21HD097400-01 | COYNE, CAROLYN B | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $234,750 | PN |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.